Literature DB >> 27006070

Effective Downsizing of a Gastroesophageal GIST Using Neoadjuvant Imatinib Mesylate: a Case Report.

Syed Asif1, Nikhil Gupta1, Gurudutt Gupta1, Anurag Mehta1, Shivendra Singh2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27006070     DOI: 10.1007/s12029-016-9816-6

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  13 in total

1.  CASE 3. Pathologic complete remission of metastatic gastrointestinal stromal tumor after imatinib mesylate.

Authors:  Matías Chacón; Enrique Roca; Eduardo Huertas; Fernando Sanchez Loria; Enzo Domenechini
Journal:  J Clin Oncol       Date:  2005-03-01       Impact factor: 44.544

2.  Resection combined with imatinib therapy for liver metastases of gastrointestinal stromal tumors.

Authors:  Lin Xia; Ming-Ming Zhang; Lin Ji; Xin Li; Xiao-Ting Wu
Journal:  Surg Today       Date:  2010-09-25       Impact factor: 2.549

3.  Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial.

Authors:  Jaap Verweij; Paolo G Casali; John Zalcberg; Axel LeCesne; Peter Reichardt; Jean-Yves Blay; Rolf Issels; Allan van Oosterom; Pancras C W Hogendoorn; Martine Van Glabbeke; Rossella Bertulli; Ian Judson
Journal:  Lancet       Date:  2004 Sep 25-Oct 1       Impact factor: 79.321

Review 4.  Recurrent rectal GIST resected successfully after preoperative chemotherapy with imatinib mesylate.

Authors:  Madoka Hamada; Kazuhide Ozaki; Tadashi Horimi; Akihito Tsuji; Yoshitsugu Nasu; Jun Iwata; Yusuke Nagata
Journal:  Int J Clin Oncol       Date:  2008-08-15       Impact factor: 3.402

Review 5.  [A case of a giant rectal gastrointestinal stromal tumor radically resectable after treatment with neoadjuvant imatinib mesylate].

Authors:  Motoki Sassa; Yusuke Kobayashi; Hidekazu Sugeno; Manabu Iwadate; Satoshi Suzuki; Yoshiyuki Endo; Izumi Nakamura; Shinji Ohki; Seiichi Takenoshita
Journal:  Gan To Kagaku Ryoho       Date:  2013-07

6.  Long-term survival after enucleation of a giant esophageal gastrointestinal stromal tumor.

Authors:  Zhi-Min Mu; Yuan-Cai Xie; Xu-Xing Peng; Hai Zhang; Gang Hui; Hao Wu; Ji-Xian Liu; Bao-Kun Chen; Da Wu; Yi-Wang Ye
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

7.  Effective Downsizing of a Large Oesophageal Gastrointestinal Stromal Tumour with Neoadjuvant Imatinib Enabling an Uncomplicated and without Tumour Rupture Laparoscopic-Assisted Ivor-Lewis Oesophagectomy.

Authors:  Kyriakos Neofytou; Mafalda Costa Neves; Alexandros Giakoustidis; Charlotte Benson; Satvinder Mudan
Journal:  Case Rep Oncol Med       Date:  2015-05-05

8.  Dramatic response of a gastrointestinal stromal tumor to neadjuvant imatinib therapy.

Authors:  Shohrat Annaberdyev; Joseph Gibbons; Jeffrey M Hardacre
Journal:  World J Surg Oncol       Date:  2009-03-16       Impact factor: 2.754

Review 9.  Optimizing surgical and imatinib therapy for the treatment of gastrointestinal stromal tumors.

Authors:  Jason K Sicklick; Nicole E Lopez
Journal:  J Gastrointest Surg       Date:  2013-06-18       Impact factor: 3.452

10.  A large esophageal gastrointestinal stromal tumor that was successfully resected after neoadjuvant imatinib treatment: case report.

Authors:  Senichiro Yanagawa; Kazuaki Tanabe; Takahisa Suzuki; Noriaki Tokumoto; Koji Arihiro; Hideki Ohdan
Journal:  World J Surg Oncol       Date:  2014-02-27       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.